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Delayed hypersensitivity is one of several im-
mune responses initiated by thymus-derived (T) 
lyrriphocytes. Other functions of T cells are listed 
in Table . 1 and summarized in reference 1. The 
mononuclear infiltrate of delayed hypersensitivity is 
a collaborative phenomenon between T lymphocytes 
and monocytes. This collaboration can be separated 
into components which I have chosen t6 call the 
"three R's'~ of delayed hypersensitivity. In this dis-
cussion I will define these "three R's" and examine 
the usefulness of this concept in clinical medicine. 
Hematoxylin and eosin sections of skin biopsied 
48 hours after intradermal injections of antigen 
characteristically show mononuclear cells around 
blood vessels and in connective tissue. As early as 
1951, however, Gell and Hinde (2) reported that 
the monocyte was the principal participant in the 
skin site. In 1963, McCluskey (3), using radio-
isotopic techniques, found that 90% of the mono-
nuclear cells in the reaction site were blood-borne 
and originated from cells that had divided 48 hours 
previously. Subsequently, cell transfer studies have 
provided conclusive evidence that the rapidly divid-
ing cells originated in the bone marrow and were 
precursors of the blood monocyte. Tiie evidence is 
as follows: 1) Injection of immune lymphocytes into 
nonimmune, irradiated recipients failed to transfer 
positive skin reactions ( 4); 2) Injection of bone 
marrow cells from nonimmune donors to sensitized, 
irradiated animals resulted in positive responses ( 5); 
3) Local injection of nonimmune macrophages into 
the skin of irradiated, sensitized recipients elicited 
positive responses in these areas ( 6). 
These studies indicated that two populations of 
cells are required to elicit delayed hypersensitivity. 
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The first are radioresistant, which were later defined 
as long-lived, T lymphocytes. The second population 
are cells of the monocyte/ macrophage system and 
are derived from radiosensitive precursors in the 
bone marrow. 
From this information we can develop a con-
cept of delayed hypersensitivity consisting of three 
components (Table 2). First, sensitized T lympho~ 
cytes, perhaps with some help from macrophages, 
recognize intradermally injected antigen. Secondly, 
antigenic contact triggers a response in sensitized 
lymphocytes. Within a few hours these cells release 
soluble mediators (7) called Iymphokines into the 
environment and later, activated small lyrriphocytes 
transform into blasts and proliferate. Thirdly, through 
the amplifying effects of lymphokines, such as migra-
tion inhibitory factor (MIF) and monocyte chemo-
tactic factor (MCF), other leukocytes, predominantly 
monocytes, accumulate at the skin .test site and 
comprise the reaction of delayed hypersensitivity. 
This mononuclear infiltrate is similar to that of any 
other chronic inflammatory reaction. The triggering 
event, however, is an immunologically specific re-
sponse of T lymphocytes. 
Techniques are available to evaluate each of the 
"three R's." The number of circulating T cells avail-
able for antigen recognition can be quantitated by 
several methods. The most widely used method at 
this time is a rosette technique. When sheep erythro-
cytes are incubated with human lymphocytes at 4 °C, 
the erythrocytes form rosettes around T cells ( 8). 
Secondly, heterologous anti-T lymphocyte serum has 
been developed (9) and may be used to quantitate 
T cells either by immunofluorescence or cytotoxicity. 
The second component, response to antigen, 
can be evaluated by measuring the lymphocyte pro~ 
Iiferative response to antigen. In these studies 
lymphocytes are cultured with test antigen for five-
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TABLE 1 
THYMUS-DERIVED LYMPHOCYTE FUNCTIONS 
1. Delayed hypersensitivity 
2. Activation of macrophages to resist infection 
3. Rejection of allografts and tumors 
4. Regulation of antibody production by B cells 
to-seven days and proliferation is assayed by measur-
ing incorporation of a radiolabeled DNA precursor. 
Alternatively, one can measure lymphokine 
production from antigenically stimulated lympho-
cytes. Migration inhibitory factor has received the 
most attention (7). Various techniques to measure 
MIF have been developed which are based on the 
inhibition of leukocyte migration by the culture 
supernatants of stimulated lymphocytes. The method 
of Rocklin and David (10) correlates well with 
delayed hypersensitivity. These workers use guinea 
pig peritoneal macrophages as effector cells. Other 
workers have substituted human "buffy coat" leuko-
cytes for guinea pig macrophages ( 11 ) . Results 
obtained with these cells as the indicator cells, how-
ever, did not always correlate with cutaneous skin 
reactivity to antigen (12). 
I prefer to measure MCF rather than MIF, 
because both response and reaction can be evaluated. 
With this technique we can detect mediator produc-
tion from a given patient's lymphocytes and also 
evaluate the capacity of that subject's monocytes to 
respond to bis own mediator. With a method to 
measure leukocyte chemotaxis, we can evaluate both 
lymphocyte and monocyte function. 
To perform this technique a chamber is divided 
into an upper and lower compartment by Nuclepore® 
membrane. Monocytes are placed in the upper cham-
ber and the chemotactic stimulants in the lower 
chamber. The specific migration of cells from the 
upper to the lower surface of the membrane filter 
is quantitated ( 13). 
These in vitro methods can be used to define 
the component that is defective in patients with 
impaired delayed hypersensitivity. Lymphocytes from 
children with a congenitally absent thymus gland 
(the DiGeorge syndrome and Nezelof syndrome) 
fail to form rosettes with sheep erythrocytes or to 
proliferate in response to mitogens. These children, 
then, do not have sufficient T lymphocytes capable 
of antigenic recognition. 
Impaired cell-mediated immunity in chronic 
mucocutaneous candidiasis may be due to several 
defects, either .in a response or reaction. Patients 
with this disease usually have adequate numbers of 
circulating lymphocytes but may have selective de-
fects in lymphocyte or monocyte function. In some 
subjects, blast transformation is intact but MIF is 
absent ( 14). In others, mediator production is intact, 
but these patients' lymphocytes fail to proliferate in 
response to antigen (15). Finally, Snyderman (16) 
reported a patient with chronic mucocutaneous candi-
diasis whose monocytes responded poorly to a 
chemotactic stimulus. Although it is tempting to 
speculate that the defects detected with in vitro 
TABLE2 
DELAYED HYPERSENSITIVITY 
A COLLABORATIVE PARTICIPATION OF LYMPHOCYTES AND MACROPHAGES 
IN AN IMMUNOLOGICALLY SPECIFIC INFLAMMATORY REACTION 
Component Assay System 
1. The recognition by small (thymus-derived) 
lymphocytes of material which is antigenic to the host. 
2. A response of sensitized lymphocytes as detected by the 
release of soluble factors (lymphokines) and later by 
cell division. 
Quantitation of T lymphocytes by: 
1. Spontaneous rosettes without sheep erythrocytes. 
2. lmmunofluorescence or cytotoxicity using heterologous 
antihuman thymocyte serum. 
Generation of lymphokines 
1. Migration inhibitory factor (MIF) 
2. Macrophage chemotactic factor (MCF) 
Blast transformation and proliferation 
3. A mononuclear inflammatory reaction, consisting Monocyte response to MCF 
predominantly of "activated" macrophages, which "Skin-window" assay 
leads to the attack, destruction, and sequestration of 
autologous or foreign materials. 
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techniques accurately reflect an in vivo disturbance, 
the data must be interpreted with appropriate caution 
at this time. 
Delayed hypersensitivity may be impaired in 
conditions without a demonstrable defect in cellular 
function . Serum factors inhibit lymphocyte function 
in certain diseases and several examples are listed 
in Table 3. The role of these serum inhibitors has 
not been defined. Moreover, primary disorders of 
lymphocyte function have not been differentiated 
from secondary effects caused by serum factor in 
many diseases with impaired cellular immunity. 
Recent studies from this laboratory suggest that 
anergy in such diverse diseases as systemic lupus 
erythematosus (SLE) and primary intracranial tu-
mors ( 17) is caused by serum inhibitors rather than 
defective cells. Fractionation of inhibitory serum 
in patients with each of these diseases revealed an 
IgG factor that broadly suppresses reactivity of 
allogeneic as well as autologous lymphocytes. This 
inhibitory lgG factor has been named lymphocyte 
regulatory immunoglobulin (LRG) and increased 
LRG in SLE may, in part, explain decreased delayed 
hypersensitivity. Patients with SLE and other dis-
eases also have a lymphocytotoxic antibody that 
may depress cell function. 
In summary, I have attempted to develop a 
working model of delayed hypersensitivity that may 
be useful in understanding areas puzzling to the non-
immunologist. The reader is urged to ask the follow-
ing questions in order to evaluate scientific papers 
dealing with defective cellular immunity in various 
diseases. First, did the patients studied have adequate 
numbers of circulating lymphocytes and monocytes? 
Secondly, did the methods used evaluate a single 
component of delayed hypersensitivity or were sev-
eral components analyzed? Finally, did the authors 
distinguish a primary cellular defect from secondary 
TABLE 3 
DISEASES WITH SERUM INHIBITORS OF LYMPHOCYTE FUNCTION 
1. Hematologic and solid tumors 
2. Systemic lupus erythematosus 
3. Tuberculosis 
4. Multiple sclerosis 
5. Hepatitis 
6. Lepromatous leprosy 
7. Ataxia telangiectasia 
8. Multiparous women 
9. Multiple transfusions 
humoral effects? Separation of delayed hypersensi-
tivity into "three R's" may be helpful in organizing 
and understanding present information. 
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